Axel Wein

762 total citations
40 papers, 573 citations indexed

About

Axel Wein is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Axel Wein has authored 40 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Axel Wein's work include Colorectal Cancer Treatments and Studies (17 papers), Gastric Cancer Management and Outcomes (11 papers) and Genetic factors in colorectal cancer (8 papers). Axel Wein is often cited by papers focused on Colorectal Cancer Treatments and Studies (17 papers), Gastric Cancer Management and Outcomes (11 papers) and Genetic factors in colorectal cancer (8 papers). Axel Wein collaborates with scholars based in Germany, United States and United Kingdom. Axel Wein's co-authors include Werner Hohenberger, Susanne Merkel, Eckhart G. Hahn, Thomas Papadopoulos, P. Hermanek, Wolfgang M. Brueckl, Frank Boxberger, Arno Dimmler, Roland S. Croner and Andreas Jung and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Axel Wein

39 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Axel Wein Germany	12	307	225	204	139	72	40	573
Madoka Hamada Japan	17	401 1.3×	370 1.6×	239 1.2×	56 0.4×	88 1.2×	64	681
Ho-Kyung Chun South Korea	13	230 0.7×	224 1.0×	116 0.6×	91 0.7×	51 0.7×	31	562
Carl Millward United States	12	294 1.0×	114 0.5×	132 0.6×	245 1.8×	83 1.2×	28	624
Hisao Matsunou Japan	10	360 1.2×	314 1.4×	203 1.0×	97 0.7×	57 0.8×	19	605
Francesca Erroi Italy	14	328 1.1×	307 1.4×	189 0.9×	113 0.8×	57 0.8×	32	587
Kiichi Maeda Japan	11	150 0.5×	172 0.8×	170 0.8×	42 0.3×	63 0.9×	52	406
Jennifer R. Scudiere United States	10	261 0.9×	325 1.4×	172 0.8×	51 0.4×	67 0.9×	19	559
Evin Büyükünal Türkiye	13	197 0.6×	103 0.5×	152 0.7×	70 0.5×	33 0.5×	37	406
Greg N. Bender United States	7	207 0.7×	251 1.1×	101 0.5×	98 0.7×	112 1.6×	9	504
Raza A. Dilawari United States	11	320 1.0×	172 0.8×	126 0.6×	228 1.6×	75 1.0×	14	522

Countries citing papers authored by Axel Wein

Since Specialization

Citations

This map shows the geographic impact of Axel Wein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Wein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Wein more than expected).

Fields of papers citing papers by Axel Wein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Wein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Wein. The network helps show where Axel Wein may publish in the future.

Co-authorship network of co-authors of Axel Wein

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Wein. A scholar is included among the top collaborators of Axel Wein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Wein. Axel Wein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stintzing, Sebastian, Jan Wierecky, Axel Wein, et al.. (2024). Encorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: First effectiveness data of the European multi-centric, multi-national, non-interventional study—BERING-CRC.. Journal of Clinical Oncology. 42(16_suppl). 3551–3551. 1 indexed citations

Vitali, Francesco, Axel Wein, Timo Räth, et al.. (2021). The outcome of patients with inflammatory bowel disease–associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer–a matched-pair analysis of survival. International Journal of Colorectal Disease. 37(2). 381–391. 6 indexed citations

Wein, Axel, Robert Stoehr, Stephan Kersting, et al.. (2021). A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI – Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results. Oncology. 100(1). 1–11. 1 indexed citations

Merkel, Susanne, Vera Schellerer, Axel Wein, et al.. (2018). The influence of tumour site on prognosis in metastatic colorectal carcinomas with primary tumour resection. International Journal of Colorectal Disease. 33(9). 1215–1223. 7 indexed citations

Wein, Axel, Juergen Siebler, Kerstin Wolff, et al.. (2017). Weekly High-dose 5-Fluorouracil as 24-hour Infusion Combined with Sodium Folinic Acid (AIO regimen) Plus Irinotecan in Second-line and Sequential Therapy of Metastatic Colorectal Cancer (CRC). Anticancer Research. 37(7). 3771–3779. 3 indexed citations

Wein, Axel, Jürgen Siebler, Ruediger S. Goertz, et al.. (2016). Successful Multidisciplinary Treatment with Secondary Metastatic Liver Resection after Downsizing by Palliative Second-Line Treatment of Colorectal Cancer: A Curative Option. Case Reports in Oncology. 9(2). 379–386. 1 indexed citations

Wein, Axel, Martin Emmert, Susanne Merkel, et al.. (2014). Palliative Treatment of Colorectal Cancer with Secondary Metastasis Resection in Germany - Impact of the Multidisciplinary Treatment Approach on Prognosis and Cost: The Northern Bavaria IVOPAK I Project. Oncology. 88(2). 103–121. 8 indexed citations

Schildberg, Claus, Werner Hohenberger, Axel Wein, et al.. (2013). Metastatic Adenocarcinomas of the Stomach or Esophagogastric Junction (UICC Stage IV) Are Not Always a Palliative Situation: A Retrospective Analysis. World Journal of Surgery. 38(2). 419–425. 6 indexed citations

Emmert, Martin, Axel Wein, Frank Dörje, et al.. (2012). Palliative treatment of colorectal cancer in Germany: cost of care and quality of life. The European Journal of Health Economics. 14(4). 629–638. 14 indexed citations

10.

Wein, Axel, Heinz Albrecht, Kerstin Wolff, et al.. (2011). Long-Term Relapse-Free Survival by Interdisciplinary Collaboration in a Patient with Metastatic Pancreatic Cancer (UICC IV). SHILAP Revista de lepidopterología. 4(2). 413–419. 1 indexed citations

11.

Wein, Axel, Peter C. Konturek, Heinz Albrecht, et al.. (2011). Palliative first-line therapy with weekly high-dose 5-fluorouracil and sodium folinic acid as a 24-hour infusion (AIO regimen) combined with weekly irinotecan in patients with metastatic adenocarcinoma of the stomach or esophagogastric junction followed by secondary metastatic resection after downsizing. Medical Science Monitor. 17(5). CR248–CR258. 7 indexed citations

12.

Croner, Roland S., Berthold Lausen, Vera Schellerer, et al.. (2009). Comparability of Microarray Data between Amplified and Non Amplified RNA in Colorectal Carcinoma. BioMed Research International. 2009(1). 837170–837170. 9 indexed citations

13.

Gentner, Bernhard, Axel Wein, Roland S. Croner, et al.. (2009). Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.. PubMed. 29(1). 67–74. 30 indexed citations

14.

Hofheinz, Ralf‐Dieter, Ulrike Gnad-Vogt, Axel Wein, et al.. (2004). Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer: a phase II study. Anti-Cancer Drugs. 16(1). 39–45. 9 indexed citations

15.

Bittorf, Birgit, et al.. (2004). Primary signet-ring cell carcinoma of the colorectum. Langenbeck s Archives of Surgery. 389(3). 178–83. 38 indexed citations

16.

Boxberger, Frank, Wolfgang M. Brueckl, Martina B. Hautmann, et al.. (2003). Palliative chemotherapy with gemcitabine and weekly high-dose 5-fluorouracil as 24-h infusion in metastatic biliary tract and gall bladder adenocarcinomas. Anti-Cancer Drugs. 14(1). 87–90. 8 indexed citations

17.

Strobel, Deike, Axel Wein, T. Bernatik, et al.. (2003). Hochfrequenzthermotherapie mit perfundierten Nadelapplikatoren bei der Behandlung primärer und sekundärer Lebertumoren. Ultraschall in der Medizin - European Journal of Ultrasound. 24(1). 27–33. 10 indexed citations

18.

Brueckl, Wolfgang M., Axel Wein, Andreas Jung, et al.. (2002). Ki-67 expression and residual tumour (R) classification are associated with disease-free survival in desmoid tumour patients.. PubMed. 21(5). 3615–20. 14 indexed citations

19.

Brueckl, Wolfgang M., Thomas Brabletz, Klaus Guenther, et al.. (2001). Mismatch repair deficiency in sporadic synchronous colorectal cancer.. PubMed. 20(6C). 4727–32. 12 indexed citations

20.

Merkel, Susanne, et al.. (2001). High-risk groups of patients with Stage II colon carcinoma. Cancer. 92(6). 1435–1443. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact